Materion Corp
NYSE:MTRN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
97
139
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Materion Corp
You don't have any saved screeners yet
Greetings. Welcome to the Materion Year End 2019 Earnings Conference Call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]
Please note this conference is being recorded. I will now turn the conference over to Stephen Shamrock. Thank you. You may begin.
Good morning. This is Steve Shamrock, Vice President, Corporate Controller and Investor Relations. With me today is Jugal Vijayvargiya, President and Chief Executive Officer; and Joe Kelley, Vice President and Chief Financial Officer.
Our format for today’s conference call is as follows. Jugal Vijayvargiya will provide opening comments on the company’s 2019 performance and the outlook as we move forward into 2020. Following Jugal, Joe Kelley will review detailed financial results for the quarter and full year highlights and then we will open up the call for questions.
Before we begin, let me remind investors that any forward-looking statements made in this announcement, including those in the outlook section and during the question-and-answer portion are based on current expectations.
The company’s actual future performance may materially differ from that contemplated by the forward-looking statements as a result of a variety of factors. Those factors are listed in the earnings press release we issued this morning.
Additionally, comments with regard to operating profit, net income, and earnings per share reflect the adjusted gap numbers shown in attachment number five in this morning’s press release. The adjustments are made in both the current year and prior year periods for comparative purposes and remove special items, non-cash pension charges and certain income tax adjustments.
And now, I will turn it over to Jugal for his comments.
Thanks, Steve, and welcome everyone. I am pleased to report another year of record financial results. We delivered earnings of $3.19 a share. That’s a 34% year-over-year improvement and it’s the third consecutive year of more than 30% earnings growth.
Our PAC and PC businesses achieved record operating profit margins. All three of our businesses reported double-digit operating profit margins for the second year. I am very proud of our global team for quickly embracing the One Materion multi-pillar strategy to deliver transformational financial performance over the past three years.
We finished the year at 11% operating profit margin. That’s a 540 basis point improvement over the last three years. ROIC came in at 15%, a 900 basis point improvement, and in 2019, we generated approximately $100 million of operating cash flow.
As you can see from these metrics, we have emerged as an advanced materials company. Our global team is fully engaged and remains enthusiastic to deliver long-term sustainable profitable growth leveraging our differentiator product portfolio and unique technical capabilities. Joe will cover additional financial details for the quarter and the full year.
Now, I will provide an update on current business conditions. We had a very successful 2019 despite challenging market conditions, which intensified in the fourth quarter in several of the end markets.
Trade and tariff situation with China continue to be a drag on sales, particularly in the telecom and data center end market. We continue to see the effects of inventory destocking and sluggish demand in several other end markets including automotive, industrial and energy. These factors are continued to impact order entry heading into the current year.
The Coronavirus outbreak is expected to further pressure near-term outlook. At this time it is very difficult to quantify the impact due to the evolving nature of the situation. Most importantly none of our global employees are infected with the virus and we are taking every measure to ensure that we protect the health and safety of our people.
Despite all these macro challenges we are entering 2020 with momentum in our aerospace and defense and semiconductor end markets. Aerospace and defense should remain a strong performer in 2020, with application wins and strong end-market demand in defense, which is expected to offset softness in aerospace. In the semiconductor market, we believe that we are starting to see a market recovery after two years of market downturn.
We are also introducing an exciting new product in this market. Aluminum Scandium targets which are critical to 5G and many devices. These products provide a competitive performance advantage for our customers.
As I have noted before it is our intent to increase funding for R&D to support long-term growth. In 2019, we have increased R&D spending by 20%. In the last three years we have increased R&D spending 43%. An important example of this is our engagement with Cosworth Engineering in Europe to build an internal combustion engine using Materion components and perform testing to generate application data, which demonstrates the superior performance of our materials.
In addition we have expanded relationships with universities and think tanks specializing in material science to explore additional opportunities. We will continue to increase investment in R&D to drive long-term organic growth, which is our top priority.
Lastly, I would like to thank our entire global team who have diligently led the progress over the last three years. Their passion for solving customer problems and embracing our One Materion multi-pillar strategy is inspiring. I have never been more excited about the company’s long-term growth potential. I look forward to providing updates on our progress in future calls.
Now, I will turn the call over to Joe to cover financials.
Thank you, Jugal, and welcome to everyone joining us on the call today. During my comments, I will cover full year and fourth quarter 2019 financial highlights, review profitability by segment, provide brief comments on the balance sheet, cash flow and modeling assumptions, and finally, cover the earnings outlook for 2020. Following my remarks, we will open the line for questions.
Let me first briefly comment on full year 2019 consolidated financial performance. Full year 2019 adjusted operating profit totaled $82.4 million, an all-time record and a 25% year-over-year increase, primarily due to performance improvements across the company related to commercial execution on product sales mix and improved manufacturing productivity and cost reductions.
Expressed as a percentage of value-added sales, adjusted operating profit was a record 11%. Value-added sales, which exclude the impact of pass-through precious metal cost, totaled $733.7 million for the full year of 2019, relatively flat, compared to $739 million in 2018. Full year 2019 adjusted earnings totaled $3.19 per share, up 34% versus 2018 adjusted earnings of $2.38 per share.
Now moving to the fourth quarter, given the macro environment, fourth quarter 2019 was challenging from a topline perspective. Fourth quarter 2019 value-added sales were $162.5 million, down 12.5%, compared to $185.8 million in the prior year fourth quarter.
We had another excellent quarter in aerospace and defense, up 24% year-over-year, driven by a combination of program wins, strong demand and the timing of a large defense order.
The Semiconductor end market sales also increased approximately 7% versus the prior year. As we are cautiously optimistic, this end market is starting to turn positive after two years of declines. These gains, however, were more than offset by significant weakness in a number of end markets, particularly automotive, industrial and telecom and data center.
In addition, we did not record any hydroxide shipments in the fourth quarter of 2019, compared to approximately $10 million in the third quarter of 2019 and $5 million in the fourth quarter of 2018.
Gross profit was $55 million or 33.8% of value-added sales in the fourth quarter versus an adjusted gross margin of $64.2 million in the prior year. The drop in gross profit compared to the prior year is due primarily to lower sales volume, offset by improved sales mix.
Selling, general and administrative expense totaled $31.4 million, down 6.3 million or 17% compared to the prior year fourth quarter, with reductions in variable expenses and aggressive cost management actions aligned with business volumes. As a percentage of value-added sales, SG&A was 19% in the current quarter, compared to 20% in 2018.
R&D expense was $5.2 million, up over 50% compared to the prior year, as we continued to make R&D investments as part of our One Materion strategy to drive long-term growth.
Operating profit totaled $16.6 million in the fourth quarter of 2019. Excluding $500,000 of special items related to external M&A cost and a legacy environmental matter, adjusted operating profit was $17.1 million or 11% of value-added sales, compared to adjusted operating profit of $18.1 million or 10% of value-added sales in the prior year.
We have now delivered six consecutive quarters of double-digit operating profit margins. Despite the decrease in sales volume, operating profit margins expanded year-over-year as our profitable growth strategy and performance based culture has driven improved product mix and aggressive operational cost and efficiency management.
Looking at income taxes, we recorded income tax expense of $1.7 million in the fourth quarter of 2019, resulting in an effective tax rate of 10%. Excluding special items related to equity compensation and a state tax law change, the effective tax rate for the quarter was 17%, bringing the full year adjusted tax rate to 18.4% in line with our previous guidance.
Adjusted net income for the fourth quarter totaled $14.1 million or $0.68 per diluted share, up 5% from an adjusted $0.65 per share recorded in the fourth quarter of 2018. This is the 12th consecutive quarter of year-over-year adjusted EPS growth and validates the commercial and operational improvements we have been making as part of our One Materion multi-pillar strategy.
Now, let me review 2019 fourth quarter performance by business segment. Starting first with performance Alloys and Composites. Value-added sales were $91.3 million, compared to 110.1 million in the prior year.
Aerospace and defense end-market sales continued to remain strong for the reasons I mentioned earlier. However, this strength was more than offset by significant decreases in the telecom and data center and automotive end markets.
The telecom and data center markets continue to be impacted by the ongoing tariff and trade situation with China. While automotive connector demand remain soft in Europe and Asia. In addition, there were no beryllium hydroxide shipments in the quarter.
Operating profit in the fourth quarter of 2019 totaled $13.6 million, compared to adjusted operating profit of $18 million in the prior year. The decrease in operating profit was driven by lower sales volume in the quarter, offset by meaningful commercial and operational performance improvements. As a percentage of value-added sales, fourth quarter operating profit was 15%, the sixth consecutive quarter of operating profit margins of 15% or greater.
We remain optimistic about the long-term growth potential of this segment based on our highly differentiated product portfolio and the commercial and R&D investments we are making. We are targeting 15% or better full-year 2020 operating profit margins.
Looking at the Advanced Materials business segment. Value-added sales in the fourth quarter 2019 were $52.8 million consistent with the prior year. We finally began to experience a year-over-year increase in the semiconductor end-market sales and are cautiously optimistic we have experienced the bottoming out of this market. These increases were offset by market weakness in industrials, as well as reduced sales in the medical end market.
Operating profit totaled $5.3 million, compared to adjusted operating profit of $4.9 million in the prior year. The 8% improvement in operating profit was led by cost reduction actions, partial offset by unfavorable product mix. As market conditions improve, we expect to make progress towards returning this business to historical operating profit margin levels.
Turning now to the Precision Coatings segment. Fourth quarter value-added sales were $19.2 million, compared to 24.2 million in the fourth quarter of 2018, due to lower sales of Large Area Coatings products into the medical end-market as previously communicated.
Operating profit for the Precision Coatings segment totaled $1.6 million in the fourth quarter of 2019, compared to $2.4 million in the fourth quarter of 2018. The year-over-year decrease in operating profit was due to lower medical sales volumes, partially offset by cost savings generated from third quarter restructuring actions.
If you recall, we mentioned on our third quarter conference call that medical sales volumes for this segment were forecasted to decline related to the sustained increased cost of palladium and lower medical reimbursement rates. In the third quarter, we recorded non-cash, goodwill and asset impairment charges, as well as a restructuring charge to right-size the cost structure for the lower sales volume.
Looking ahead, we expect continued growth in our optical filter product line of this segment, which will partially offset the expected year-over-year decline in blood glucose test strip sales. We are targeting double-digit profit margins for 2020 for this segment.
Moving now to the balance sheet and cash flow. We generated cash flows from operations of $99 million, an all-time record due to strong operating results and a significant reduction in inventory levels.
As a result, we ended the year in a net cash position of $123 million and have significant available liquidity to support capital allocation priorities, including organic growth opportunities, inorganic growth opportunities and consistently return capital to shareholders.
For financial modeling purposes in 2020, cash outflows for capital spending should run approximately $30 million, mine development investments should be approximately $10 million to $12 million, annual depreciation and amortization should run approximately $35 million, the effective tax rate should be 18% to 20%.
And finally, now the earnings outlook for 2020, we had a very successful 2019, delivering record level profits, despite a significant slowdown in the fourth quarter due to macroeconomic headwinds impacting several key end markets, including automotive, telecom and data center and energy. These headwinds are expected to continue into the first quarter of 2020, along with the added uncertainty of the economic impact of the Coronavirus outbreak.
At a more company specific level, we remain focused on making commercial and operational investments to drive profitable long-term growth. Based on these factors, we are guiding full-year 2020 earnings to range from $3.15 per share to $3.30 per share. Using the midpoint of this range, it would represent the fourth consecutive year of earnings growth.
From a quarterly guidance perspective, the first quarter will be challenged by the low incoming order rate experienced in late 2019, the lower fourth quarter production volumes, which pressure manufacturing cost and the uncertainty related to the impact of the Coronavirus on business levels.
We expect the first quarter of 2020 earnings to be sequentially down approximately 10% to 15% versus the fourth quarter of 2019 adjusted earnings. Most, if not all, of these challenges in the first quarter we view as temporary in nature and the remaining quarters of 2020 are forecasted to rebound to profit levels more comparable to those experienced in the first three quarters of 2019.
This concludes our prepared remarks. We will now open the line for questions.
Thank you. [Operator Instructions] Our first question comes from Edward Marshall of Sidoti & Company.
Hey gentlemen. Good morning.
Good morning, Ed.
Good morning, Ed.
So wanted to speak on the beryllium and the no shipments in the quarter, I am wondering if there was anything contractually structured in the contract that you signed a few years ago with the customer that may have caused that or whether it was timing or maybe just destocking in the market, if you could elaborate a little bit please?
Yeah. Ed, the contract that we signed with our customer is more on an annual basis, in terms of what the sales would be on an annual basis. We typically model that it would go across the four quarters, but there is no requirement quarter to quarter.
So there is timing and it just depends on what the needs may be at their level and what our production rate can be and so the combination of the two is what we end up using to deliver. So there is no contractual issue there. There is no specific special issue. It’s just a matter of how things worked out as we managed 2019.
Got it. So they just took their minimums earlier in the year than they normally would?
Yeah. That’s in effect what happened.
Got it. When I look at the AM -- go ahead.
As you know, the third quarter was very strong in that area.
Of course. Of course. In fact the whole year has been pretty strong. It looked like they front-loaded into the first three quarters. When I look at AM, I can see the improvement on the revenue. I am curious if you could kind of talk about the gross margin that continues to decline a little bit. I am wondering if that is competitive forces, whether that’s pricing -- giving up on pricing or just kind of operational issues as you kind of come off the lower base? Thanks.
Yeah. So on AM, we have made significant progress. In fact, I would say, on the operational front. As you know, we went through a cost reduction effort in our European facility. We made good progress on that and we got that in place. So the operational side I think continues to perform well.
On the AM side, what we continue to face though is a little bit of a mix issue with the Semiconductor business along with some of the other areas. Our Large Area Targets business, which is one of the components of that business actually had a very strong year.
That business doesn’t generate the same level of returns that maybe some of the other businesses in that segment do and so I think the mix was a big contributing factor on the AM. But I would say on the operational front, things have continued to improve and our expectation is that that business will get back to historical margins as the market recovery, particularly in semiconductor, continues to happen.
We have a lot of ramp actually of some new products that we are in the process of doing, so some of those -- sometimes, as you know, during the ramp-up, there are some ramp up costs that happen. So aluminum-scandium is one of the areas that we talked about in fact in the prepared remarks earlier as well. So I expect that business over time to get back to the historical margins.
And just to be clear, does the R&D run through the specific segment level or does it run through -- I know this wouldn’t affect gross margin, but does it run through the segment level, or does it run through the corporate level?
It runs through each of the segment levels.
Okay. And so, if I step back for a second to talk about the gross margin in that business, are you alluding to the fact that most of the operational changes have already been in place, the heavy lifting has been done and as we see the mix shift back to semi, we should ultimately see the gross margin rebound and that brings you back to historic levels. Is that…
Yeah.
Is that what I understood from your comment?
Yeah. As you know, semi had a really a two-year significant downturn and we started to see just very, very small signs of pick up here in the fourth quarter. Our expectation is that maybe the pickup will now start to get a little bit bigger and bigger every quarter.
But one of the things that, of course, everybody is facing right now is this whole Coronavirus thing. So we will have to see what -- if there is this delay, okay, in the pickup that was starting to come through.
The other thing that I think is an important factor for us is the new product introductions that are at a much better profitability level than some of the outgoing products as well. So, I think, combination of the semiconductor pick up, the macro environment with the virus subsiding and then the new product introductions launching. Those are all contributing factors to improving the margins.
Got it. As far as the health concerns are concerned -- are related, AM is your biggest exposure, I guess, to maybe even from a sourcing perspective and a shipment perspective, is that correct?
Well, I mean, yeah, from a direct China health perspective, we do have a manufacturing plant for the AM business. We actually have a manufacturing plant for our Precision Coatings business as well. We have been monitoring that almost daily from here. We have got a few leaders in China and in Asia that are monitoring it and as of right now, we are -- we can say that we are clean and we are doing everything we can to support our employee base there.
In terms of the customer impact, more of the business impact, supply chain impact, I think it actually goes across all three of our businesses, because AM certainly from the electronics and the semiconductor side, but a lot of our PAC business particularly strip products they end up in the China market, and then, we of course have a plan for our Precision Coatings business and our Displays business. So, actually all three of our businesses will have direct and indirect impact for the virus situation.
Okay. Okay. Final one for me, the coating products for 5G that you mentioned the new product, was that in-house developed under the traditional Materion or is that from the acquired Heraeus business? Thanks.
No. That is in house from -- that’s primarily led by our Milwaukee business and produced in one of our facilities here in North America. And so it’s part of the R&D effort that we really have to drive growth, organic growth and so it is something that is the, let’s call it, the legacy Materion business.
Great. Thank you very much for all your time.
Okay. Thanks, Ed.
Our next question comes from Martin Englert of Jefferies.
Hi. Good morning, everyone.
Good morning Martin.
Hi, Martin.
So some of this you touched on in your prepared remarks, but I wanted to circle back on it, when thinking about your guidance. Can you discuss some of the end markets here and maybe provide a little bit more granular detail on what end markets you expect to see growth year-on-year in 2020 and value-added sales, and conversely, those that you have factored in kind of flat and or negative trends?
Yeah. Yeah. So from an end-market perspective as we ended the year and then also into the new year, we see, as I indicated, a little bit of a light at the end of the tunnel so to speak on semiconductor after two years of tough, tough going there.
So semiconductor is a market that we see I think on more of the positive side. I think defense is going to be a strong -- continue to be a strong market for us. We may have some challenges in terms of year-over-year comps, because we had a very strong 2019, in particular, with a couple of very large orders towards the end of the year. So year-over-year comps may be challenged, but in general, it will still be -- we expect it to be a strong market.
But then the other markets, be it automotive, telecom data center, energy, medical, you name it. I mean, I think, those markets we would expect neutral to negative is what our expectation is for this year.
We are just not seeing the uptick. If you take automotive, for example, reports out last night that China was down 18% in January, expectation from the European Auto Manufacturers Association that Europe may be down 2% this year, et cetera.
So we are just not seeing the signs yet in some of these other areas. Oil and gas, rig count continues to go down as of just here a few days ago. I think it was below 800, which is a level that has not been seen since three years ago, March of ‘17.
So some of those markets I think we would see as neutral to negative with the semiconductor being on perhaps on the plus side and Defense, I would say, being a little bit on the plus side as well. And then related to semiconductor is of course consumer electronics, which we would perhaps see as a small uptick as well.
Okay. And kind of taking all those together, does -- are you anticipating value-added sales will be down year-on-year, as a result of some of these stagnant, more challenging end-markets, when you kind of sum everything up?
Yeah. As you know, Martin, we don’t comment on value-added sales and we provide guidance at the earnings level. But I think based on the earnings level that we have provided, the performance improvements that we will continue to drive, the -- some of the market challenges that we just mentioned, the new product introductions that we have. I would expect us to be able to still deliver some level of modest growth, but it is going to be a very challenging year.
Okay. Got it. Understood. And looking at value-added sales within aerospace and defense, can you provide a little bit more detail on what the mix is associated with commercial aero?
Yeah. As you know, commercial aero is something that has been a challenging market for us for ‘19 and we expect those challenges to continue because one of our largest customers is a large customer that’s facing some difficulties right now, whereas the defense side is fairly robust.
In terms of just the size of the defense versus the aerospace component, I mean, you could almost say almost kind of like a 2-to-1 ratio, maybe defense is more like a two-thirds and aerospace is about a third, I think, of the split. But we continue to see challenges on the aerospace side and then, as I said, in Defense. So we expect to have some tough year-over-year comps, but still a good market.
Okay. And if I could, one last one here and you touched on this before and noted that factoring in risk around the virus is pretty difficult to quantify. But is there some aspect of your quarter-on-quarter earnings or full year that you are baking in some type of earnings headwinds associated with the Coronavirus?
Yeah. So, I think, on the first quarter with this 10% to 15% sequential guide down that we have indicated. We are factoring in some level of, I will say, direct and indirect impact. But on a full year basis, our expectation at this time is that the recovery will happen and then this impact is just a short-term impact, recovery will happen and it will get recovered whatever losses that the market would show us in the beginning of the year would get recovered.
So, obviously, if those assumptions don’t come true, then we will have to relook at the guidance. But at this stage our expectation is and with what we have communicated is we are trying to factor in for Q1, but for the full year we are expecting full recovery.
Okay. I appreciate all the detail and congratulations on another solid year of earnings growth.
Okay. Thanks, Martin.
Our next question comes from Marco Rodriguez of Stonegate Capital. Please go ahead.
Good morning, guys. Thank you for taking my question.
Good morning, Marco.
Hi.
I wanted to follow-up again on the Advanced Materials section, just the semiconductor area, obviously, you have talked about the mix issues that have sort of impacted the margins and how your thought is that once that mix sort of switches, then it will be a lot easier for you guys to obtain that historical operating margin perspective.
But wondering if maybe you can talk a little bit more about that mix aspect. Is this something that is controlled by you in terms of a sales initiative? Is it a particular product line that at the moment is depressed because of the lull that semiconductor market has had and expectation is that comes back or is it new product that’s supposed to overtake the mix issue?
Yeah. So, I think, as we look at on a go-forward basis, I’d say, it’s a combination, right? One, we are doing a lot on new product introductions and pushing our sales force and our development teams to work with our customers and introduce new products and new technologies.
I mentioned this aluminum-scandium as an example of something that that we are really pushing, going and knocking on doors and trying to make sure that we get a strong foothold as that technology takes off. So it definitely is I think things that we can do from that front.
And then the second part, of course, is just the market recovery, we need the market after two years of continued downturn to have a meaningful recovery. I mentioned that we are starting to see some signs of it, but those signs were right towards the end of last year and I would say very, very small signs and then now with this virus impact, as I said, there may be another gap and we will have to wait and see.
So I think it’s a combination, where we can control with new product growth and new product introductions that we are doing and market recovery. But I would say, a meaningful market recovery versus just the initial signs that we started to see.
Understood. And is there an expectation in terms of your guidance, at least for that segment, the Advanced Materials, that towards the tail end of fiscal ‘20 that you start to hit those mid-teen type operating margins or is that something that maybe is a ‘21 event?
Yeah. I think, clearly, we have internal expectations, but I think just in terms of our general expectation for that business. I mean, our objective is to continue to make progress every quarter in that business. And at some point, whether it’s in ‘20 or perhaps in ‘21 be able to get to those historical margins. So we don’t have a specific timeline that we are ready to communicate at this stage, but we just want to make sure we can demonstrate progress every quarter.
I will just add, if you look at a full year basis. We did expand the operating profit margin of that business -- that segment ‘19, full year ‘19 over ‘ 18. So we are starting to make some progress.
Absolutely. Absolutely. Okay. Then, switching gears here on to the difficult aspect of looking at the Coronavirus and its impact, you mentioned you have a couple plants in China. Are they open, are they running right now or are they still down?
Yeah. So we took an extra week where we had shut those plants down, similar to many other facility, many other companies did. So we restarted on February 10th. However, I will tell you that we do not have a full workforce at this stage. There is a number of people that we have made sure. We are following through with some sort of home quarantine because we want to be extra cautious for them, as well as their coworkers.
So right now we are open with those two plants on a limited basis and we would expect that over the next couple of weeks they would be back to full production. But it will also depend of course on orders and order entry that we get. But we will be prepared to do full production in a couple more weeks.
Got it. And maybe you could share if you have had any sort of conversations with end -market customers, just any sort of sense in terms of what they are thinking about in terms of the supply chain impact, because obviously, there’s going to be some push out.
Yeah.
Some people are starting to come back, some people aren’t.
Yeah.
I don’t think that necessarily you are going to lose orders but it’s definitely pushing to the right?
Yeah. So, right now, as you know, we are typically a Tier 2, Tier 3 in many cases. So we don’t feel the impact right away. But we start to see some effects of it in terms of just, like you said, general wording and some general commentary. So we are starting to hear from our customers that they are very concerned, of course.
In terms of actual orders and orders declining, we have not received order decline, I would say, as of today, but our expectation is that I think we will see impact here in the very near future.
Got it. And I will ask the question, if I might, expectations for the hydroxide shipments in fiscal ‘20, is it still a kind of flat line across all four quarters or any sort of indication from customer in terms of how they might order this year?
Yeah. It’s, as you know, we expect that to be basically flat on a year-over-year basis, I mean, typical $15 million to $20 million that we estimate. For modeling purposes, we estimate that to be basically every quarter, all four quarters. However, we know that there could be some timing issues here and there based on what the customer decides to do, but at this stage we have modeled it for our purposes as if it’s throughout the year.
Thanks a lot guys. Appreciate your time.
Okay. Thank you.
Thanks, Marco.
Our next question comes from Michael Leshock of KeyBanc Capital Markets. Please go ahead.
Hey guys. Good morning.
Good morning, Michael.
Good morning.
So you talked a little bit about the new products ramping in 2020. Could you talk about how you see the cadence of these ramp ups throughout the year?
Yeah. So when we look at, for example, this aluminum-scandium that I spoke about. That’s something that we started to launch, I would say, towards the end of last year, but at a very low volume. We expect that to continue to ramp throughout the year. We think that that will continue to ramp this year, as well as into next year as well. So I think we see that as I said throughout the year.
When we look at our engineered strip product, we have a project that we are working on with one of our customers and we would expect that project to launch in the second half of the year. So that will be a nice pickup for us in the second half of the year, provided that we can make sure the customer and us, we continue with the timing.
We have a number of other products that we are working on. But I would say they are kind of sprinkled during the year. So there is not a -- I am not able to give you any specific uptick that would happen in one quarter versus another, sharp uptick that would happen in one quarter versus another.
Got it. And then on the 737 Max, just what impact have you seen thus far and is there anything you are able to do to kind of mitigate that impact going forward?
Yeah. So we have seen impact, I mean, we don’t talk about specific customer or a specific product impact. But we definitely have seen an impact with that, but then in general with that customer, because it’s not just at that particular plane impact.
If you look at our Aero business, it was down 4 million I think in the quarter, so year-over-year, down $4 million. Defense business on the other hand was up. So what we are really doing is trying to manage that overall aerospace and defense as a market by pushing really on the defense side while this temporary setback on the aero side.
I am just wondering on your M&A strategy. Could you talk a little bit about how you view the current environment and is this a consideration in your guidance?
Yeah. I mean, we are absolutely focused on the M&A front. I mean, we made significant progress, as you know, on the organic side driving performance improvements over the last three years and we are very, very focused on driving top-line growth on the organic side, making investments as we indicated on the R&D side, 43% increase over the last three years, 20% increase year-over-year last year.
So we continue to push on the organic growth and our guidance and the numbers that we communicate to you are clearly based on more of an organic front. But we are very heavily focused on the M&A side and provided that we find the right opportunity, we would make the necessary move this year.
Okay. Then lastly for me, just a modeling question, how should I think about projected pension expense and contribution in 2020 versus 2019?
Yeah. So as you recall, we did freeze our pension plans, our defined benefit pension plan and switched all employees to one consistent defined contribution plan. And so down in other net expense below OP, above EBIT, you should see about a $2 million to $3 million benefit.
Got it. Thanks guys.
Thanks. And cash contributions this year will be zero, whereas historically as you recall we have averaged around $15 million, $16 million.
Our next question is a follow-up from Edward Marshall of Sidoti & Company.
The PAC delta on -- I guess, sequentially looking at beryllium hydroxide, I just wanted to come back to that for a second. It looks like the delta there might be $10 million, maybe $11 million in revenue or value-added revenue.
Yes. Right. $10 million.
About $10 million, okay? Is the delta on the EBIT line for that business all attributable to the beryllium hydroxide…
Yeah. Typically we don’t…
… optically it looks like it’s pretty close.
Yeah. We don’t obviously disclose the profitability of individual product lines with individual customers, so we can’t comment on that.
I think there is a lot -- as you know, there is a lot of pluses and minuses that happen in the business, right? I mean, clearly that customer volume down is one, but there is various performance changes.
As we mentioned earlier, our defense business was up, our aero business was down and there’s a lot of mix that happens. So if the number seems to you if it’s maybe in line with that type of a number, I think, it’s just a matter of coincidence because there is a lot of pluses and minuses that happen to get to the overall profit number.
Right. I recall that energy is a pretty good mix item for you in that business as well?
Absolutely.
You are correct.
You are correct.
Okay.
Yeah.
Okay. Thanks very much.
Okay. All right. Thanks.
Thanks Ed.
This concludes the question-and-answer session. I will now turn the call over to Mr. Shamrock for closing remarks.
Thank you. This is Steve Shamrock and this concludes our fourth quarter 2019 earnings call. A recorded playback of this call will be available on the company’s website materion.com. We would like to thank all of you for participating on the call this morning and your interest in Materion. I will be available to answer any follow-up questions. My direct number is 216-383-4010. Thank you very much.
This concludes today’s conference call. You may disconnect your lines. Thank you for participating and have a pleasant day.